share_log

424B5: Prospectus

424B5: Prospectus

424B5：募资说明书
美股SEC公告 ·  2024/09/17 05:32

Moomoo AI 已提取核心信息

ZyVersa Therapeutics, a biopharmaceutical company, has filed a Form 424B5 with the Securities and Exchange Commission. This filing is typically associated with the registration of securities for a company's public offering. The document, identified as form424b5.htm, indicates that ZyVersa Therapeutics is potentially preparing to offer securities to investors, although the specific details of the offering such as the type of securities, the amount, and the timing were not disclosed in the provided announcement text.
ZyVersa Therapeutics, a biopharmaceutical company, has filed a Form 424B5 with the Securities and Exchange Commission. This filing is typically associated with the registration of securities for a company's public offering. The document, identified as form424b5.htm, indicates that ZyVersa Therapeutics is potentially preparing to offer securities to investors, although the specific details of the offering such as the type of securities, the amount, and the timing were not disclosed in the provided announcement text.
ZyVersa Therapeutics，一家生物医药公司，已向美国证券交易委员会提交了Form 424B5。这种申报通常与公司公开招股的证券注册相关。该文件被标识为form424b5.htm，表明ZyVersa Therapeutics可能正在准备向投资者发行证券，尽管提供的公告文本中没有透露该发行的具体细节，如证券类型、金额和时间。
ZyVersa Therapeutics，一家生物医药公司，已向美国证券交易委员会提交了Form 424B5。这种申报通常与公司公开招股的证券注册相关。该文件被标识为form424b5.htm，表明ZyVersa Therapeutics可能正在准备向投资者发行证券，尽管提供的公告文本中没有透露该发行的具体细节，如证券类型、金额和时间。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Dogwood Therapeutics
    DWTX
    -- 3.150
    Camp4 Therapeutics
    CAMP
    -- 6.540
    Channel Therapeutics
    CHRO
    -- 2.660
    Allakos
    ALLK
    -- 1.110
    Nutriband
    NTRB
    -- 5.210
    解锁完整榜单
    热门中概股
    追踪最热门的中概股实时资讯。
    热门讨论
    特朗普回归，财报发布在即：特斯拉能否继续攀升？
    🎙️讨论： 1. 面对特朗普回归，特斯拉股价能否在2025年继续攀升？ 2. 特斯拉将在1月29日盘后公布财报，你认为会超出市场预期吗？ 展开
    特斯拉第四季度下跌：是时候买入，还是风险太高了？📉